RT Journal Article
SR Electronic
T1 Vaccinations or Non-Pharmaceutical Interventions: Safe Reopening of Schools in England
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.07.21263223
DO 10.1101/2021.09.07.21263223
A1 Cuesta-Lazaro, Carolina
A1 Quera-Bofarull, Arnau
A1 Aylett-Bullock, Joseph
A1 Lawrence, Bryan N.
A1 Fong, Kevin
A1 Icaza-Lizaola, Miguel
A1 Sedgewick, Aidan
A1 Truong, Henry
A1 Vernon, Ian
A1 Williams, Julian
A1 Pagel, Christina
A1 Krauss, Frank
YR 2021
UL http://medrxiv.org/content/early/2021/09/23/2021.09.07.21263223.abstract
AB With high levels of the Delta variant of COVID-19 circulating in England during September 2021, schools are set to reopen with few school-based non-pharmaceutical interventions (NPIs). In this paper, we present simulation results obtained from the individual-based model, June, for English school opening after a prior vaccination campaign using an optimistic set of assumptions about vaccine efficacy and the likelihood of prior-reinfection. We take a scenario-based approach to modelling potential interventions to assess relative changes rather than real-world forecasts. Specifically, we assess the effects of vaccinating those aged 16-17, those aged 12-17, and not vaccinating children at all relative to only vaccinating the adult population, addressing what might have happened had the UK began teenage vaccinations earlier. Vaccinating children in the 12-15 age group would have had a significant impact on the course of the epidemic, saving thousands of lives overall in these simulations. In the absence of such a vaccination campaign our simulations show there could still be a significant positive impact on the epidemic (fewer cases, fewer deaths) by continuing NPI strategies in schools. Our analysis suggests that the best results in terms of lives saved are likely derived from a combination of the now planned vaccination campaign and NPIs in schools.Competing Interest StatementThe authors have declared no competing interest.Funding Statementt. J.A.B., C.C.L., A.Q.B. thank the STFC-CDT DDIS for their support through grant ST/P006744/1. F.K. gratefully acknowledges funding as a Royal Society Wolfson Research Fellow. We gratefully acknowledge the generous provision of computing time on the Hartree and JASMIN facilities. The bulk of this work used the DiRAC@Durham facility managed by the Institute for Computational Cosmology on behalf of the STFC DiRAC HPC Facility (www.dirac.ac.uk). The equipment was funded by BEIS capital funding via STFC capital grants ST/K00042X/1,ST/P002293/1, ST/R002371/1 and ST/S002502/1, Durham University and STFC operations grant ST/R000832/1. DiRAC, Hartree and JASMIN are part of the National e-Infrastructure.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was not required for this study as the data we use is open. We use the Health Research Authority (HRA)decision tool and consulted HRA formally who provided formal acknowledgment of our exemption.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made availble on Zenodo or a similar repository before publication.